Ceres Aktie $$$ NEWS $$$ WKN: A14RPB ISIN: US1567734009 Symbol: CERE Typ: Aktie http

+ Antworten
2Antworten
  1. Avatar von Hotlevel
    Hotlevel ist offline
    Themen Starter

    Title
    Erfahrener Benutzer
    seit
    06.04.2014
    Beiträge
    101
    Danke
    1

    Daumen hoch Ceres Aktie $$$ NEWS $$$ WKN: A14RPB ISIN: US1567734009 Symbol: CERE Typ: Aktie http

    Ceres Aktie $$$ NEWS $$$
    WKN: A14RPB
    ISIN: US1567734009
    Symbol: CERE
    Typ: Aktie

    CERES AKTIEN News | A14RPB Nachrichten | US1567734009

    Investors Hub - Charts

    Ceres Awarded Patent for Innovation in Soybean
    Date : 05/27/2015 @ 7:45AM
    Source : PR Newswire (US)
    Stock : Ceres, Inc. (MM) (CERE)
    Quote : 3.77 2.09 (124.40%) @ 12:00PM

    Ceres Awarded Patent for Innovation in Soybean
    Print
    Ceres, Inc. (MM) (NASDAQ:CERE)
    Intraday Stock Chart

    Today : Wednesday 27 May 2015
    Click Here for more Ceres, Inc. (MM) Charts.

    THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology company, has been awarded a U.S. patent for a genetic sequence derived from soybean, covering uses of the gene in areas such as research, product development and plant transformation. The company believes that its gene is useful in regulating key biosynthetic processes that are the target of a class of commercial herbicides. Ceres plans to offer other seed companies a commercial license to the innovation, including an opportunity for exclusivity in certain crops.

    Richard Hamilton, President and CEO of Ceres, said that the company is currently evaluating the potential market for this gene among soybean seed companies and the use of its patented invention in the development and production of improved soybean varieties.

    Ceres' biotechnology platform, which has proven to increase crop productivity, raise quality, reduce crop inputs and improve cultivation on marginal land, has broad application across multiple markets and crops.

    Hamilton noted that growers are facing increasing demand for food, feed, fiber and fuel as a result of rising global population and an expanding middle class in certain regions. "The need for technology improvements has become more pressing due to stresses from climate variability and competition for water resources," said Hamilton. "Agricultural biotechnology has and will continue to represent a significant source of innovation for increasing crop yields through improving performance of seeds."

    The new patent for this invention was issued by the U.S. Patent and Trademark Office as U.S. Patent No. 9,024,004 and is titled, Sequence-Determined DNA Fragments Encoding Acetohydroxyacid Synthase Proteins. Ceres owns or maintains exclusive licensed rights to approximately 85 issued patents and numerous pending patent applications in the United States and in various foreign jurisdictions. A patent is an intellectual property right granted by a government to an inventor to exclude others from making, using, offering for sale, or selling the invention for a limited time in exchange for public disclosure of the invention when the patent is granted.

    Soybean is one of the most valuable and widely planted row crops in the world. From 2003 to 2013, the number of acres planted increased 2.4% annually, to 275 million acres today, according to the Food and Agriculture Organization of the United Nations. Soybeans are used for oil, feed for livestock and aquaculture, as a biofuel feedstock and as a protein for the human diet.

    About Ceres
    Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds to produce crops for forage, biofuels and other markets that utilize plant biomass. The company's advanced plant breeding and biotechnology technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology, including its Persephone genome visualization software, to other life science companies and organizations.

    Ceres Forward-Looking Statements
    This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products and technologies, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from the company's plan to align expenditures and projected cash expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

    To view the original version on PR Newswire, visit:Ceres Awarded Patent for Innovation in Soybean -- THOUSAND OAKS, Calif., May 27, 2015 /PRNewswire/ --

    SOURCE Ceres, Inc.

    Copyright 2015 PR Newswire

  2. Avatar von Hotlevel
    Hotlevel ist offline
    Themen Starter

    Title
    Erfahrener Benutzer
    seit
    06.04.2014
    Beiträge
    101
    Danke
    1

    Daumen hoch AW: Ceres Aktie $$$ NEWS $$$ WKN: A14RPB ISIN: US1567734009 Symbol: CERE Typ: Aktie

    Ceres skyrockets after winning U.S. patent for soybean innovation
    May 27 2015, 14:11 ET | By: Carl Surran, SA News Editor [Contact this editor with comments or a news tip]

    Ceres (CERE +101.8%) shares more than double after the agricultural biotech company says it received a U.S. patent for a genetic sequence derived from soybeans affecting plant development and transformation such as boosting yields or adapting soybeans for biofuel production.
    CERE believes the gene has applications in regulating major biosynthetic practices related to commercial herbicides, and aims to market a commercial license for its innovation to other seed businesses, which also includes an option for exclusivity in specific crops.
    CERE says soybean is one of the most popular and profitable cash crops in the world, as the number of acres farmers planted increased 2.4%/year during 2003-13 to 275M acres worldwide.

    765 people get CERE breaking news and analysis by email alert.

    Ceres skyrockets after winning U.S. patent for soybean innovation - Ceres, Inc. (NASDAQ:CERE) | Seeking Alpha

  3. Avatar von Hotlevel
    Hotlevel ist offline
    Themen Starter

    Title
    Erfahrener Benutzer
    seit
    06.04.2014
    Beiträge
    101
    Danke
    1

    Daumen hoch AW: Ceres Aktie $$$ NEWS $$$ WKN: A14RPB ISIN: US1567734009 Symbol: CERE Typ: Aktie

    CERE $$$ NEWS Ceres Continues Realignment Toward Food and Feed Markets and Biotech Traits

    Ceres, Inc. (MM) (NASDAQ:CERE)
    Intraday Stock Chart

    Today : Friday 19 June 2015
    Click Here for more Ceres, Inc. (MM) Charts.

    THOUSAND OAKS, Calif., June 19, 2015 /PRNewswire/ -- Ceres, Inc. (Nasdaq: CERE), an agricultural biotechnology company, today announced the continued realignment of its business to focus on food and forage opportunities and biotechnology traits for sugarcane and other crops. As part of the realignment, the company will restructure its Brazilian seed operations and is exploring discussions with additional local partners and collaborators to support the continued development and commercialization of its technology in Brazil.

    Earlier this year, the company announced that due to the economic challenges faced by the Brazilian ethanol industry as well as changes in the global energy market, it had expanded the number of market opportunities available for its technology and products and began prioritizing its working capital in additional areas beyond Brazil. The company's current restructuring plan is intended to further align expenditures toward improved forages for dairy and meat production and biotech traits for sugarcane and other crops.

    "These changes represent an important step in the transformation of our business as we refocus on our strengths in agricultural technology and direct our attention to markets being fueled by global prosperity growth," said Ceres President and CEO Richard Hamilton. He noted that bioenergy markets have continued to face serious near-term challenges due to low oil prices, the struggling Brazilian economy, delays in second generation refining technology and unfavorable government policies, among other headwinds. "If these challenges can be surmounted then I believe the market for bioenergy feedstocks can reemerge as a global opportunity for agricultural technology companies like Ceres."

    Brazilian Operations
    Ceres indicated that its Brazilian operations after implementation of the restructuring plan would be focused primarily on sorghum breeding and sugarcane. In particular, the company plans to expand its sugarcane trait development activities for the Brazilian sugarcane market, which Ceres expects to fund, in part, under a grant available from the Brazilian government.

    "Given the economic climate in Brazil, and the time horizon needed to bring our top performing sorghum hybrids to market, we believe that the best path forward is to work with a more focused group of well-capitalized mills and collaborators," said Paul Kuc, Ceres Chief Financial Officer. "Moreover, our advances in sugarcane biotechnology and compelling field trial results are making Brazilian sugarcane a more attractive use of capital."

    The realignment plan, which is expected to be substantially completed by October 31, 2015, includes, among other actions, a workforce reduction that will impact 14 positions in Brazil primarily related to administration, operations and manufacturing as well as 2 support positions in the United States. Ceres estimates that it will incur total charges of approximately $0.6 million over the next five months with respect to these workforce reductions in Brazil and the U.S., including $0.1 million in continuation of salary and benefits of certain employees until their work is completed and their positions are eliminated, and $0.5 million of one-time severance and other costs, all of which will be cash expenditures. The company expects to achieve additional cost reductions as part of the realignment, which may include additional workforce reductions. Once fully implemented, the company's realignment plan is expected to deliver cash savings of up to approximately $6.0 to $8.0 million in fiscal year 2016.

    In addition to the realignment in Brazil, the company continues to evaluate options available for additional funding, including public or private debt or equity financings, collaborations, licensing arrangements, government programs, or the sale of intellectual property, technology or other assets.

    About Ceres
    Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds to produce crops for forage, biofuels and other markets that utilize plant biomass. The company's advanced plant breeding and biotechnology technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology, including its Persephone genome visualization software, to other life science companies and organizations.

    Ceres Forward-Looking Statements
    This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding Ceres' efforts to develop and commercialize its products and technologies, anticipated yields and product performance, status of crop plantings, short-term and long-term business strategies, market and industry expectations, future operating metrics, and future results of operations and financial position, including anticipated cost savings from the company's restructuring plan and projected cash expenditures, are forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond Ceres' control. Factors that could materially affect actual results can be found in Ceres' filings with the U.S. Securities and Exchange Commission. Ceres undertakes no obligation to update publicly, except to the extent required by law, any forward-looking statements for any reason after the date the company issues this press release to conform these statements to actual results or to changes in the company's expectations.

    To view the original version on PR Newswire, visit:Ceres Continues Realignment Toward Food and Feed Markets and Biotech Traits -- THOUSAND OAKS, Calif., June 19, 2015 /PRNewswire/ --

    SOURCE Ceres, Inc.

    Copyright 2015 PR Newswire

Ähnliche Themen

  1. Antworten: 1
    Letzter Beitrag: 22.12.2015, 20:36
  2. Tui-Aktie

    Von KSL Investments im Forum Wirtschaft, Börsen & Märkte
    Antworten: 28
    Letzter Beitrag: 13.02.2007, 17:24